Business
Organigram Reports First Quarter Fiscal 2025 Results
17% growth in net revenue to $42.7 million year-over-year $2.3 million growth in internat...
About this update from Organigram Global Inc.
[{"type":"text","content":"Organigram Reports First Quarter Fiscal 2025 Results\n\n\n .bwalignc { text-align: center; list-style-position: inside }\n.bwalignl { text-align: left }\n.bwalignr { text-align: right; list-style-position: inside }\n.bwblockalignl { margin-left: 0px; margin-right: auto }\n.bwcellpmargin { margin-bottom: 0px; margin-top: 0px }\n.bwleftsingle { border-left: solid black 1pt }\n.bwlistcircle { list-style-type: circle }\n.bwlistdisc { list-style-type: disc }\n.bwmarginl1 { margin-left: 30px }\n.bwpadb3 { padding-bottom: 4px }\n.bwpadl0 { padding-left: 0px }\n.bwpadl1 { padding-left: 5px }\n.bwpadl4 { padding-left: 20px }\n.bwpadr0 { padding-right: 0px }\n.bwrightsingle { border-right: solid black 1pt }\n.bwrowaltcolor0 { background-color: #cceeff }\n.bwsinglebottom { border-bottom: solid black 1pt }\n.bwtablemarginb { margin-bottom: 10px }\n.bwtopsingle { border-top: solid black 1pt }\n.bwvertalignb { vertical-align: bottom }\n.bwvertalignm { vertical-align: middle }\n.bwwidth10 { width: 10% }\n.bwwidth100 { width: 100% }\n.bwwidth12 { width: 12% }\n.bwwidth2 { width: 2% }\n.bwwidth64 { width: 64% }\n.bwwidth76 { width: 76% }\n.bwwidth8 { width: 8% }\n \n\n\n\n\n\n 17% growth in net revenue to $42.7 million year-over-year\n \n\n\n\n $2.3 million growth in international sales year-over-year\n \n\n\n\n Adjusted EBITDA\n \n 1\n \n of $1.4 million versus $0.1 million in the prior year period\n \n\n\n\n Completed acquisition of Motif to become recreational cannabis market leader in Canada\n \n\n\n\n Launched Edison Sonics with proprietary\n \n FAST™\n \n nanoemulsion technology, clinically validated to have up to 50% faster onset and nearly 2x impact of cannabinoids at peak\n \n\n\n\n Strong balance sheet with negligible debt, and a pro-forma cash position of $113 million\n \n 2\n \n\n\n\n\n\n\n Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended December 31, 2024 (“Q1 Fiscal 2025”). The Q1 Fiscal 2025 results include the financial results of Motif Labs Ltd. (\"Motif\") from December 6, 2024 to December 31, 2024, following the Company's acquisition of Motif.\n \n\n\n Q1 FISCAL 2025 HIGHLIGHTS\n \n\n\n\n Net revenue increased 17% to $42.7 million from $36.5 million in th...